Literature DB >> 14563692

Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation.

Karen Francis1, B Mary Lewis, Hiroyasu Akatsu, Peter N Monk, Stuart A Cain, Maurice F Scanlon, B Paul Morgan, Jack Ham, Philippe Gasque.   

Abstract

Two-way communication exists between the endocrine and immune systems using molecules such as hormones and cytokines. Here we describe a new pathway by which C3a, a complement-derived cytokine, stimulates anterior pituitary hormone release and activates the hypothalamic-pituitary-adrenal axis, a reflex central to the stress response and to the control of inflammation. We show that C3a receptors are expressed in pituitary hormone secreting and non-hormone secreting (folliculostellate) cells and that both C3a and C3adesArg (a non-inflammatory metabolite) stimulate pituitary cell cultures to release prolactin, growth hormone, and adrenocorticotropin. Serum levels of these hormones, together with adrenal corticosterone, increase dose dependently with recombinant C3a and C3adesArg administration in vivo. Pertussis toxin blocks the response to C3a but not C3adesArg, which indicates the presence of two receptors, only one of which is coupled to Galphai-proteins. We propose that the complement innate immune molecules (cytokines) modulate tissue-specific and systemic inflammatory responses through communication with the endocrine pituitary gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563692     DOI: 10.1096/fj.02-1103fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

Review 1.  Pituitary function during severe and life-threatening illnesses.

Authors:  C Gauna; G H van den Berghe; A J van der Lely
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells.

Authors:  Sebastien Hannedouche; Valerie Beck; Juliet Leighton-Davies; Martin Beibel; Guglielmo Roma; Edward J Oakeley; Vincent Lannoy; Jerome Bernard; Jacques Hamon; Samuel Barbieri; Inga Preuss; Marie-Christine Lasbennes; Andreas W Sailer; Thomas Suply; Klaus Seuwen; Christian N Parker; Frederic Bassilana
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

Review 4.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

5.  CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.

Authors:  Sarah A Ingersoll; Carol B Martin; Scott R Barnum; Brian K Martin
Journal:  Mol Immunol       Date:  2010-09-01       Impact factor: 4.407

6.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

7.  Time-dependent mediators of HPA axis activation following live Escherichia coli.

Authors:  Z R Zimomra; V M Porterfield; R M Camp; J D Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-14       Impact factor: 3.619

Review 8.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

10.  Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks.

Authors:  Xia Yang; Joshua L Deignan; Hongxiu Qi; Jun Zhu; Su Qian; Judy Zhong; Gevork Torosyan; Sana Majid; Brie Falkard; Robert R Kleinhanz; Jenny Karlsson; Lawrence W Castellani; Sheena Mumick; Kai Wang; Tao Xie; Michael Coon; Chunsheng Zhang; Daria Estrada-Smith; Charles R Farber; Susanna S Wang; Atila van Nas; Anatole Ghazalpour; Bin Zhang; Douglas J Macneil; John R Lamb; Katrina M Dipple; Marc L Reitman; Margarete Mehrabian; Pek Y Lum; Eric E Schadt; Aldons J Lusis; Thomas A Drake
Journal:  Nat Genet       Date:  2009-03-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.